Company / Capital Expenditures
SELLAS Life Sciences Group, Inc. Capital Expenditures History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$6.0K
FY2016
5-year range
-
FY2015-FY2016
Trend
-96.1%
vs FY2015
Sector context
#188 of 194
Health Care
What the data says
Among 194 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 3% for capital expenditures.
Based on SEC 10-K filings.
$6,000 in FY2016.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 194This company $6.0K Sector average $117.5M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2016, capital expenditures decreased 96.1% year-over-year.
- Ranks #188 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $6.0K | -96.1% |
| FY2015 | $153.0K | +168.4% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026